Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
fda
life sciences
national blog main
san diego blog main
san diego top stories
akcea therapeutics
alnylam pharmaceuticals
barry greene
bial
boston
boston blog main
boston top stories
boston university
dan ollendorf
drug development
drugs
hereditary transthyretin amyloidosis
inotersen
john berk
mary o'donnell
national top stories
neurocrine
neurodegeneration
neuroscience
new york blog main
new york top stories
opicapone
parkinson's disease
patisiran
regeneron pharmaceuticals
rna interference
san diego
san francisco blog main
san francisco top stories
tafamidis
the amyloidosis foundation
the institute for clinical and economic review
vyndaqel
What
fda
patients
2
×
time
2
×
add
ago
alnylam
approve
awaits
biological
called
carbidopa
combination
control
crossed
daily
decades
decision
discovered
disease
experience
fingers
friday
gets
historic
levodopa
medication
medicine
neurocrine
nod
parkinson’s
pill
rna
symptoms
trick
uses
Language
unset
Current search:
patients
×
biotech
×
time
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
